Bristol-Myers reported a loss of $130 million, or eight cents a share, compared with a year-earlier profit of $333 million, or 20 cents a share. "Bristol-Myers Results Lifted by Immunotherapy Drug Opdivo," at 7:36 a.m. ET, misstated the year-earlier figures.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Bristol Myers Squibb Charts.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Bristol Myers Squibb Charts.